Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients
Open Access
- 1 April 2012
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 53 (4) , 802-809
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Effects of Nicotinic Acid on Gene Expression: Potential Mechanisms and Implications for Wanted and Unwanted Effects of the Lipid-Lowering DrugThe Journal of Clinical Endocrinology & Metabolism, 2011
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissueAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver diseaseJournal of Lipid Research, 2010
- Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: Randomized comparison of fenofibrate 160mg and niacin 1500mgAtherosclerosis, 2010
- Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2010
- Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic SteatohepatitisHepatology, 2009
- Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population #Hepatology, 2009
- Mutation screen and association studies in the Diacylglycerol O-acyltransferase homolog 2 gene (DGAT2), a positional candidate gene for early onset obesity on chromosome 11q13BMC Genomic Data, 2007
- The Effect of Nicotinic Acid on the Plasma Free Fatty Acids Demonstration of a Metabolic Type of SympathicolysisActa Medica Scandinavica, 1962